Cogent Biosciences Inc. (cogt 1.625 11/15/31)
13F holders, Q1 2026 (March 31)3holders +1
2new positions
1sold out
$1.23avg. 13F price*
At the end of Q1 2026, 3 institutions reported holding Cogent Biosciences Inc. (cogt 1.625 11/15/31) in their 13F filings, up 1 from Q4 2025. 2 opened new positions and 1 sold out. The largest holders were Ssi Investment Management LLC ($5.5M), Polar Capital Holdings Plc ($4.6M) and Janus Henderson Group PLC ($4.5M).
- Company
- Cogent Biosciences Inc. (cogt 1.625 11/15/31)
- CUSIP
- 19240QAA0
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $9.9M |
| Exits | 1 | $15K |
All 13F filers, Q4 2025 → Q1 2026: 8,108,000 shares bought and 1,813,000 shares sold, net +6,295,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Ssi Investment Management LLC | 0.45% | New | 4,453,000 | $5.5M |
| Polar Capital Holdings Plc | 0.02% | Reduce -32.7% | 3,700,000 | $4.6M |
| Janus Henderson Group PLC | 0.00% | New | 3,655,000 | $4.5M |
"% of holder's portfolio" is COGENT BIOSCIENCES INC (COGT 1.625 11/15/31)'s weight in each manager's 13F, not the share of Cogent Biosciences Inc. (cogt 1.625 11/15/31) the manager owns.